Alex Rodriguez

If Alex Rodriguez cheated, it was just to help the Yankees win

63 Comments

Maybe it’s just me, but I see a great deal of irony in the idea that Alex Rodriguez, years after all of the allegations and admissions, with hundreds of millions of dollars already earned, was still trying to cheat in 2012.

What, pray tell,  did Rodriguez have to gain by cheating, nine years after he said he stopped. Fame? I imagine he already had more than he’d like. Money? He does have $30 million possibly coming to him if he sets home run records. That’s essentially equal to one year’s extra salary for a guy who has already taken home about $300 million. The admiration of an adoring American populace? Fat chance.

I’m not writing to defend Alex Rodriguez. I abhor the act of cheating. I understand it, though. I’d be very tempted to do it myself if millions of dollars were at stake, as would so many others who are quick to condemn. For that reason, I’m pretty rational about the cheaters themselves.

But if we believe A-Rod’s first story, he never cheated until after he got his huge, $252 million contract from the Rangers. I don’t necessarily buy that, especially in light of today’s news, but obviously, he didn’t stop once he got his cash, as someone who was simply in it for the money might have done.

So, what is this all about, if not money? In my opinion, it’s about winning. Alex Rodriguez, for whatever faults he may have, has always desperately wanted to win. Sometimes it’s caused him to try too hard. I’m mostly referring to some postseason struggles in saying that, but it could also be applied to injecting powerful and potentially harmful substances into his body. A-Rod wants to win. And he wants to be liked, by teammates and fans both, which is another obvious product of winning.

Here we were in 2010, 2011, 2012. Rodriguez is signed through 2017. Nothing he did those seasons was going to affect his next contract. He’s making $30 million per year. He’s already admitted to steroid use early in his career, which would seem to make it imperative that he never again be caught with such substances if he wanted any chance of getting into the Hall of Fame when the time came.

And, yet, he put it all into jeopardy, according to today’s account in the Miami New Times.

In my eyes, whatever Rodriguez personally had to gain by using steroids was dwarfed by what he could lose by continuing to cheat. The potential voiding of his contract. Alienating the fans who had forgiven him. Endorsements. The rain of boos in every stadium he plays in going forward. What is that against an extra year’s salary?

Maybe I don’t know. I’m not a professional athlete, much less one of the greatest to ever play the game. I don’t have any real insight into what’s going on in Rodriguez’s head. In my head, it’s simply mind-blowing that Rodriguez would continue to cheat after everything that’s happened. That’s the main reason I have some doubts about today’s news; not the report itself but that Dr. Bosch was treating the actual Rodriguez and not some A-Rod he made up on paper.

Because this Rodriguez seemed to have so very much more to lose than to gain by cheating. If he did it anyway, wasn’t it all in the name of making the Yankees better? More wins, more championships, more love. I don’t see what else it could have been about.

Nick Cafardo: Red Sox should deal Pomeranz, not Buchholz

BOSTON, MA - SEPTEMBER 18: Drew Pomeranz #31 of the Boston Red Sox pitches during the first inning against the New York Yankees at Fenway Park on September 18, 2016 in Boston, Massachusetts. The Red Sox won 5-4. (Photo by Rich Gagnon/Getty Images)
Getty Images
4 Comments

The Red Sox might be trying to move the wrong pitcher, according to the Boston Globe’s Nick Cafardo. Cafardo revealed that while the Sox have been trying to market right-hander Clay Buchholz, more teams would be interested in trades involving southpaw Drew Pomeranz.

The club appears reluctant to deal Pomeranz, especially because his price tag comes in at a cool $4.7 million to Buchholz’s $13.5 million in 2017. Those who have already expressed interest in the veteran hurlers, including the Twins, Mariners and Royals, also seem put off by Buchholz’s salary requirements as he enters his 32nd year.

Health could be another factor preventing teams from jumping to make trade offers, as Cafardo quotes an AL executive who believes the “medicals on both Pomeranz and Buchholz probably aren’t that great.” Neither pitcher suffered any major injuries during the 2016 season, though Pomeranz missed just over a week of play due to forearm soreness.

Pomeranz outperformed his fellow starter in 2016, pitching to a 3.32 ERA and career-best 9.8 K/9 through 170 2/3 innings with the Padres and Red Sox. He got off to an exceptionally strong start in San Diego, where his ERA dropped to 2.47 through the first half of the year before the Padres dealt him to Boston for minor league right-hander Anderson Espinoza. Buchholz, on the other hand, struggled with a 4.78 ERA and saw a decline in both his BB/9 and K/9 rates as he worked out a career-low 1.69 K/BB through 139 1/3 innings with the Sox.

Report: Arquimedes Caminero likely to sign with Yomiuri Giants

SEATTLE, WA - AUGUST 21: Arquimedes Caminero #48 of the Seattle Mariners delivers a pitch during a game against the Milwaukee Brewers at Safeco Field on August 21, 2016 in Seattle, Washington. The Brewers won the game 7-6. (Photo by Stephen Brashear/Getty Images)
Getty Images
Leave a comment

Mariners’ right-hander Arquimedes Caminero is nearing a deal with the Yomiuri Giants of Nippon Professional Baseball, according to Bob Dutton of the Tacoma News Tribune. The club has reportedly agreed to sell the 29-year-old’s contract, Dutton writes, though no official move has been announced by either team yet. Caminero is under club control through 2020 and currently ineligible for arbitration.

The right-hander began the 2016 season with the Pirates but was sent to the Mariners in a trade for Seattle minor leaguers Jake Brentz and Pedro Vasquez in order to clear space in the Bucs’ bullpen. With the Mariners, Caminero produced a 3.66 ERA and 8.2 K/9 through 19 2/3 innings in the second half of the year. Although he boasts an electric fastball, one which consistently averaged 98.7 m.p.h. in 2016, his success rate has been tempered by poor control throughout his major league career. According to Dutton, the Mariners’ willingness to sell Caminero’s contract was a strong indication that they did not see him as a viable contender for their 2017 bullpen or as a potential trade chip further down the line.

Should the deal go through, the right-hander will be the second former Mariner to sign with a Japanese club for the 2017 season. Per Dutton’s report, outfielder Stefen Romero also picked up a contract with the Orix Buffaloes of NPB in late November.